Annovis Bio (ANVS) Shares Outstanding (2019 - 2026)

Annovis Bio has reported Shares Outstanding (Entity) for 8 years, with the latest figure at $28.5 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 46.45% year-over-year to $28.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.5 million (up 46.45% YoY) and the FY2025 annual result came in at $20.6 million, up 45.33% from the prior year.
• Shares Outstanding (Entity) climbed to $28.5 million in Q1 2026 per ANVS's latest filing, from $20.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $28.5 million in Q1 2026 and troughed at $8.2 million in Q1 2022.
• A 5-year average of $13.4 million and a median of $11.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) rose 0.65% in 2023, then surged 76.97% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $8.2 million in 2022, then increased by 28.86% to $10.5 million in 2023, then surged by 34.43% to $14.1 million in 2024, then surged by 45.33% to $20.6 million in 2025, then surged by 38.85% to $28.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $28.5 million, $20.6 million, and $20.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.